144 related articles for article (PubMed ID: 20025554)
1. Combination therapy with mitiglinide and voglibose improves glycemic control in type 2 diabetic patients on hemodialysis.
Abe M; Okada K; Maruyama T; Maruyama N; Matsumoto K
Expert Opin Pharmacother; 2010 Feb; 11(2):169-76. PubMed ID: 20025554
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of mitiglinide in diabetic patients on maintenance hemodialysis.
Abe M; Okada K; Maruyama T; Maruyama N; Matsumoto K
Endocr J; 2010; 57(7):579-86. PubMed ID: 20467165
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy of pioglitazone with voglibose improves glycemic control safely and rapidly in Japanese type 2-diabetic patients on hemodialysis.
Abe M; Kikuchi F; Kaizu K; Matsumoto K
Clin Nephrol; 2007 Nov; 68(5):287-94. PubMed ID: 18044260
[TBL] [Abstract][Full Text] [Related]
4. Glucose excursions and hypoglycemia in patients with type 2 diabetes treated with mitiglinide/voglibose versus glimepiride: A randomized cross-over trial.
Fujimoto K; Shibayama Y; Yamaguchi E; Honjo S; Hamasaki A; Hamamoto Y
J Diabetes; 2018 Aug; 10(8):675-682. PubMed ID: 29493100
[TBL] [Abstract][Full Text] [Related]
5. Glycemic/metabolic responses to identical meal tolerance tests at breakfast, lunch and dinner in Japanese patients with type 2 diabetes mellitus treated with a dipeptidyl peptidase-4 inhibitor and the effects of adding a mitiglinide/voglibose fixed-dose combination.
Ono Y; Kamoshima H; Nakamura A; Nomoto H
Expert Opin Pharmacother; 2014 Sep; 15(13):1785-95. PubMed ID: 25046055
[TBL] [Abstract][Full Text] [Related]
6. Mitiglinide/voglibose fixed-dose combination improves postprandial glycemic excursions in Japanese patients with type 2 diabetes mellitus.
Ono Y; Kameda H; Cho KY
Expert Opin Pharmacother; 2013 Mar; 14(4):361-70. PubMed ID: 23414242
[TBL] [Abstract][Full Text] [Related]
7. Effects of sitagliptin or mitiglinide as an add-on to acarbose on daily blood glucose fluctuations measured by 72 h subcutaneous continuous glucose monitoring in Japanese patients with type 2 diabetes: a prospective randomized study.
Osonoi T; Saito M; Tamasawa A; Ishida H; Osonoi Y
Expert Opin Pharmacother; 2014 Jul; 15(10):1325-35. PubMed ID: 24866329
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of fixed-dose mitiglinide/voglibose combination and glimepiride on vascular endothelial function and glycemic variability in patients with type 2 diabetes: A randomized controlled trial.
Tanaka K; Okada Y; Umezu S; Hashimoto R; Tomoyose Y; Tateyama R; Hori Y; Saito M; Tokutsu A; Sonoda S; Uemura F; Kurozumi A; Tanaka Y
J Diabetes Investig; 2024 Apr; 15(4):449-458. PubMed ID: 38149694
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized, multicenter trial comparing the efficacy and safety of the concurrent use of long-acting insulin with mitiglinide or voglibose in patients with type 2 diabetes.
Son JW; Lee IK; Woo JT; Baik SH; Jang HC; Lee KW; Cha BS; Sung YA; Park TS; Yoo SJ; Yoon KH
Endocr J; 2015; 62(12):1049-57. PubMed ID: 26411328
[TBL] [Abstract][Full Text] [Related]
10. Differences between Mitiglinide/Voglibose Fixed-dose Combination and Glimepiride in Modifying Low-density Lipoprotein Heterogeneity in Japanese Type-2 Diabetic Patients: A Pilot Study.
Tani S; Nagao K; Hirayama A
Drug Res (Stuttg); 2016 Feb; 66(2):94-9. PubMed ID: 26011816
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Efficacy of Repaglinide Versus the Combination of Mitiglinide and Voglibose on Glycemic Variability in Japanese Patients with Type 2 Diabetes.
Okada H; Tanaka M; Hasegawa G; Nakajima H; Kadono M; Okada Y; Hirata A; Oyamada H; Yamane T; Fukui M
Curr Pharm Des; 2020; 25(43):4600-4605. PubMed ID: 31538887
[TBL] [Abstract][Full Text] [Related]
12. Tighter control of postprandial hyperglycemia with mitiglinide/voglibose fixed-dose combination in Japanese patients with type 2 diabetes mellitus.
Inoue M
Expert Opin Pharmacother; 2012 Nov; 13(16):2257-68. PubMed ID: 22994875
[TBL] [Abstract][Full Text] [Related]
13. The glycemic/metabolic responses to meal tolerance tests at breakfast, lunch and dinner, and effects of the mitiglinide/voglibose fixed-dose combination on postprandial profiles in Japanese patients with type 2 diabetes mellitus.
Ono Y; Nakamura A; Cho KY; Nomoto H
Expert Opin Pharmacother; 2014 Feb; 15(3):311-24. PubMed ID: 24328511
[TBL] [Abstract][Full Text] [Related]
14. Add-on treatment with mitiglinide improves residual postprandial hyperglycemia in type 2 diabetic patients receiving the combination therapy with insulin glargine and sitagliptin.
Murakami T; Nambu T; Kato T; Matsuda Y; Yonemitsu S; Muro S; Oki S
Tohoku J Exp Med; 2015 Apr; 235(4):255-60. PubMed ID: 25810423
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of postprandial endogenous insulin secretion rather than exogenous insulin injection ameliorated insulin antibody-induced unstable diabetes: a case report.
Kaneko K; Satake C; Izumi T; Tanaka M; Yamamoto J; Asai Y; Sawada S; Imai J; Yamada T; Katagiri H
BMC Endocr Disord; 2019 Jan; 19(1):5. PubMed ID: 30621663
[TBL] [Abstract][Full Text] [Related]
16. Effects of mitiglinide, a short-acting insulin secretagogue, on daily glycemic variability and oxidative stress markers in Japanese patients with type 2 diabetes mellitus.
Kodani N; Saisho Y; Tanaka K; Kawai T; Itoh H
Clin Drug Investig; 2013 Aug; 33(8):563-70. PubMed ID: 23797928
[TBL] [Abstract][Full Text] [Related]
17. Effect of mitiglinide on glycemic control over 52 weeks in Japanese type 2 diabetic patients insufficiently controlled with pioglitazone monotherapy.
Kaku K; Tanaka S; Origasa H; Kikuchi M; Akanuma Y
Endocr J; 2009; 56(6):739-46. PubMed ID: 19506328
[TBL] [Abstract][Full Text] [Related]
18. Concomitant use of miglitol and mitiglinide as initial combination therapy in type 2 diabetes mellitus.
Tatsumi F; Hashiramoto M; Hirukawa H; Kimura T; Shimoda M; Tawaramoto K; Kanda-Kimura Y; Anno T; Kawasaki F; Mune T; Matsuki M; Kaku K
Diabetes Res Clin Pract; 2013 Jul; 101(1):35-44. PubMed ID: 23711593
[TBL] [Abstract][Full Text] [Related]
19. Additive postprandial glucose-lowering effects of mitiglinide and sitagliptin in patients with type 2 diabetes mellitus.
Jung JA; Kaku K; Kim JH; Kim JR; Ko JW; Lee SY; Huh W
Adv Ther; 2013 Nov; 30(11):1018-29. PubMed ID: 24249434
[TBL] [Abstract][Full Text] [Related]
20. Addition of mitiglinide to pioglitazone monotherapy improves overall glycemic control in Japanese patients with type 2 diabetes: a randomized double blind trial.
Kaku K; Tanaka S; Origasa H; Kikuchi M; Akanuma Y
Endocr J; 2009; 56(5):657-64. PubMed ID: 19352048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
